Abstract
Health agencies, including the Centers for Disease Control and Prevention (CDC) and World Health Organization (WHO), recommend different temperature thresholds for electric fan use during heat events (CDC: 32.2° C; WHO: 40° C). Nonetheless, these guidelines do not account for physiological effects of fan on immune and inflammatory responses in males and females. This study evaluated the efficacy of electric fan use in mitigating immune function, inflammation, and organ function during an eight-hour simulated extreme heat event replicating conditions in Hangzhou, China, on the August 3, 2024 (semi-hourly temperature and humidity fluctuations; average temperature: 39.9° C [37.6-41.1° C] & RH: 47.1% [40-57%]). Thirty-two young adults (16 males and 16 females) underwent three eight-hour trials: (1) no electric fan with limited fluid intake (500mL; Con), (2) fan use with limited fluid intake (500mL; Fan) and (3) fan use with sufficient fluid intake (3L; Fan+Fluid). Core temperature, cardiovascular responses, plasma electrolytes, stress hormones, inflammatory markers, and organ function biomarkers were assessed. Fan+Fluid significantly reduced core temperature, stress hormone levels, inflammatory responses, and organ function biomarkers in both sexes (all p<0.05). Notably, Fan+Fluid greatly reduced IL-6, IL-1β, ALT and BUN by 23.9%, 32.5%, 15.9% and 23.6%, respectively, compared to CON, despite the core temperature difference is marginal. Females exhibited consistently higher stress hormone levels, inflammatory responses, and organ function markers than males across all trials (all p<0.05). These findings highlight the benefits of electric fan use in prolonged extreme heat and suggest that females may require more intense cooling interventions due to heightened inflammatory and organ stress responses.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by a NSFC Excellent Young Scientists grant
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRB of Xian University of Science and Technology gave the ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos